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Abstract
Introduction: Primary central nervous system lymphoma and its subtype, primary dural lymphoma, are types of non-
Hodgkin’s lymphoma that only occur in the central nervous system without any dissemination. They are extremely rare
cases of extra nodal lymphomas accounting for 1–5% of intracranial tumors. Case report: We present a patient diagnosed
with primary dural lymphoma in right frontal brain region who underwent surgical resection. Histopathological analysis
revealed diffuse B-type large cell non-Hodgkin lymphoma. Patient underwent four cycles of R-CHOP and intrathecal metho-
trexate protocol. Six months postoperative, no signs of newly onset inﬁltration were present. Discussion: Primary dural
lymphoma most likely presents with unusual radiological signs, which can easily be mistaken for meningioma, the main
differential diagnosis. A thorough immunological, histopathological and clinical patients proﬁle should be conducted in
order to establish the certainty of diagnosis. Although there are few treatment options: surgery, radiotherapy or chemother-
apy, there is no established treatment protocol.
INTRODUCTION
Primary dural lymphoma (PDL) is a subtype arising from a lar-
ger group called primary central nervous system lymphomas
(PCNSL). PCNSL are extra nodal non-Hodgkin lymphomas ori-
ginating from the brain, meninges or spinal cord, but in the
absence of systemic involvement [1]. This pathology is
accounted for less than 1% of all central nervous system (CNS)
lymphomas and <0.1% of all non-Hodgkin’s lymphomas gener-
ally [2]. The real occurrence of PDL is not yet known. Two lar-
gest series describing PDL had only 8 and 15 patients [3, 4].
Lymphomas can be roughly divided based on arising site into
nodal and extra nodal. PDL arises from the dura mater and
belongs to the low-grade B-cell marginal zone group of tumors
which is non-speciﬁc for CNS pathologies which are mostly
high-grade diffuse large B-cell lymphomas [1]. Marginal zone
lymphomas are a torpid non-Hodgkin type of lymphoma and
they occur more frequently in the gastrointestinal system
(MALT lymphomas) [1, 4]. Usually the preferential site of dissem-
ination for MALT lymphomas is within other organs of MALT
system, but they can also be noticed in non-gastrointestinal
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tissue such as skin, salivary glands [5]. One of their characteris-
tics is a localized disease, just like PDL, which shares a lot of fea-
tures with marginal zone B-cell lymphomas.
CASE REPORT
A 34-year-old male patient was presented with a 2-month history
of intermittent headaches in the right frontal region. No other sig-
niﬁcant neurological deﬁcits were found. Initial magnetic resonance
imaging (MRI) revealed mass in the right frontal part of the skull
(Fig. 1). The mass was attached to dura mater and it was mildly
compressing the middle frontal gyrus beneath. Also, signs of
intraosseal propagation were present. Patient underwent right side
frontal craniectomy. Bone attached to the tumor was extracted.
Duroplasty and cranioplasty were performed. Surgery went without
complications. Postoperative computerized tomography (CT) was
satisfying. Tissue samples from multiple sites of tumor connected
to dura with surrounding bone were taken intraoperatively and
underwent histopathological analysis. Tumor consists of large cells
with pleomorphic nuclei and prominent nucleoli, with pathological
mitotic ﬁgures. Tumorous tissue shows immunohistological reactiv-
ity for CD45 LCA, CD20, CD79a, CD10, BCL6 and PAX5. They were
partly positive for BCL2 and CD30 and negative for CD3 and CD21.
C-myc shows positivity in 36% of tumor cells. Proliferation index
Ki67 is diffusely 75% (Fig. 2). According to WHO classiﬁcation it cor-
responds to diffuse large B-cell lymphoma. Afterwards, extended
diagnostics were performed. Bone marrow biopsy showed an
abnormality in the percentage of non-segmented neutrophils of
Figure 1: Initial brain MRI showing extra-axial mass in the right frontal part of anterior cranial fossa in (a) transverse and (b) coronal plain.
Figure 2: Microphotography of tumorous tissue with ﬁbrous tissue of dural origin on the edge of the surgical material, measuring together 5 cm in greatest diameter:
(a) hemalaun eosin staining, magniﬁcation of ×400; (b) immunohistological reactivity BLC6, magniﬁcation of ×400; (c) immunohistological reactivity CD20, magniﬁca-
tion of ×400; (d) immunohistological reactivity CD45 LCA, magniﬁcation of ×100; (e) immunohistological reactivity CD79, magniﬁcation of ×400; and (f) proliferation
index Ki67, magniﬁcation of ×400.
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17%. Other results showed medium–high erythropoiesis with nor-
mal cell ratios but without ﬁndings of malignant alteration or inﬁl-
tration. A cylindrical sample showed no morphological nor
immunohistochemical (CD20, PAX5, Ki67 and CD3) evidence of
malignant inﬁltration. Lumbar puncture was also performed and
cerebrospinal ﬂuid (CSF) samples showed no positivity to malignant
cells. Afterwards, full body CT was performed, followed by ultra-
sound including thyroid and salivary glands. Also, MRI of brain
and spinal cord was done. All conducted imaging methods
revealed normal anatomical and structural features without
traces of lymph node enlargement or ﬂee ﬂuid throughout the
body. A hematologist was consulted and methotrexate or R-CHOP
therapy was recommended.
The patient was transferred to the hematology department
for further diagnostic procedures. Upon analysis no pathological
ﬁndings were found. After consultation R-CHOP and intrathecal
methotrexate protocol was chosen. The patient was administered
four cycles of R-CHOP and intrathecal methotrexate. Four months
afterwards, MRI and neurosurgical control were performed. MRI
revealed satisfying postoperative result without any new intra-
cranial masses (Fig. 3).
DISCUSSION
Meningeal involvement of lymphoma as a result of a systemic
disease can occur extremely rare. For patients with PDL the
most predominant histopathological ﬁnding is marginal zone
B-cell lymphoma, frequently found in the GI system as mucosa
associated lymphoid tissue [4].
When suspecting a PCNSL, of primary importance is CT and
MRI, especially contrast enhanced MRI, because differential
diagnosis with the highest level of importance is meningioma
[1, 2, 6]. Other differential diagnoses include dural metastasis,
ﬁbrous tumors, gliosarcomas, leiomyosarcomas or neurosarcoi-
dosis [1, 3]. MRI reveals single or multiple extra-axial masses;
mostly more than one mass. Perilesional edema is usually not
excessive and mainly depends on mass size and location.
Respectively, cerebral convexities are the most common site of
involvement, but other sites such as falx, tentorium and sellar
or suprasellar regions can be affected. Since the most common
site of masses is cerebral convexity, intraoseal propagation
occasionaly occurs [1].
More rarely, intraventricular and spine located masses can
be found. Lumbar puncture as well as CSF cytology and ﬂow
cytometry should always be performed, respectively. A
thorough analysis of the CSF should be done to minimalize the
possibility of free ﬂoating tumor cell seeding and to perform
evaluation of the intradural space.
It is yet to be understood the biological basis of the dural
space involvement. Due to scarce materials and its rarity, the
mechanism of PCNSL malignant transformation point of access
in the CNS and origin of malignant cells are insufﬁciently known.
Outside the CNS, marginal zone B-cell lymphomas are believed to
derive from inﬂammation processes due to infectious organisms
or autoimmune diseases which tends to open the question of
infectious or autoimmune co-etiology in PCNSL [4]. Also worth
mentioning is the fact that dura is outside the blood–brain barrier
and this increases the risk of PDL systemic relapse.
Different drugs and procedures were tried out, such as com-
plete surgical resection, systematic or intrathecal chemotherapy
with CHOP, rituximab, methotrexate, alkylating agents, cytara-
bine and vincristine [1, 6]. Methotrexate based approach in treat-
ing primary lymphomas is the most effective way, especially
when combined with brain irradiation; the survival rates are
around 70% [1]. PDL tends to respond positively to surgery and
radiotherapy. They are preferable choices due to its indolent
character and high radio sensitivity but requires relatively low
doses of radiotherapy [1, 3]. Although there are limited reports
and PDL is quite rare, further investigations in this ﬁeld are
required in order to develop the most effective treatment option.
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